vs
GLAUKOS Corp（GKOS）与MARCUS CORP（MCS）财务数据对比。点击上方公司名可切换其他公司
MARCUS CORP的季度营收约是GLAUKOS Corp的1.3倍（$193.5M vs $150.6M），GLAUKOS Corp同比增速更快（41.2% vs 2.8%），过去两年GLAUKOS Corp的营收复合增速更高（25.4% vs 18.2%）
Glaukos Corp是一家专注于眼科领域的医疗科技企业，开发并商业化用于治疗青光眼、角膜疾病等眼部病症的微创手术器械、处方药物及消费级产品，主要市场覆盖北美、欧洲及亚太地区，为全球医院、眼科诊所及患者提供服务。
马库斯公司是一家美国企业，主营商业地产领域相关服务，业务覆盖美国与加拿大，提供商业地产经纪、按揭经纪、行业研究以及咨询服务，首创了由单一经纪公司独家代理房源挂牌的行业模式，目前在美加两国设有超过80家办公室，拥有员工超1800名。
GKOS vs MCS — 直观对比
营收规模更大
MCS
是对方的1.3倍
$150.6M
营收增速更快
GKOS
高出38.4%
2.8%
两年增速更快
GKOS
近两年复合增速
18.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $150.6M | $193.5M |
| 净利润 | $9.4M | — |
| 毛利率 | 77.9% | — |
| 营业利润率 | 9.0% | 0.9% |
| 净利率 | 6.2% | — |
| 营收同比 | 41.2% | 2.8% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GKOSMCS
| Q1 26 | $150.6M | — | ||
| Q4 25 | $143.1M | $193.5M | ||
| Q3 25 | $133.5M | $210.2M | ||
| Q2 25 | $124.1M | $206.0M | ||
| Q1 25 | $106.7M | $148.8M | ||
| Q4 24 | $105.5M | $188.3M | ||
| Q3 24 | $96.7M | $232.7M | ||
| Q2 24 | $95.7M | $176.0M |
净利润GKOSMCS
| Q1 26 | $9.4M | — | ||
| Q4 25 | $-133.7M | — | ||
| Q3 25 | $-16.2M | $16.2M | ||
| Q2 25 | $-19.7M | $7.3M | ||
| Q1 25 | $-18.1M | $-16.8M | ||
| Q4 24 | $-33.6M | $986.0K | ||
| Q3 24 | $-21.4M | $23.3M | ||
| Q2 24 | $-50.5M | $-20.2M |
毛利率GKOSMCS
| Q1 26 | 77.9% | — | ||
| Q4 25 | -1.1% | — | ||
| Q3 25 | 78.4% | — | ||
| Q2 25 | 78.3% | — | ||
| Q1 25 | 77.2% | — | ||
| Q4 24 | 72.9% | — | ||
| Q3 24 | 76.6% | — | ||
| Q2 24 | 76.4% | — |
营业利润率GKOSMCS
| Q1 26 | 9.0% | — | ||
| Q4 25 | -97.7% | 0.9% | ||
| Q3 25 | -12.3% | 10.8% | ||
| Q2 25 | -18.3% | 6.3% | ||
| Q1 25 | -19.4% | -13.7% | ||
| Q4 24 | -27.2% | -1.2% | ||
| Q3 24 | -25.5% | 14.1% | ||
| Q2 24 | -31.3% | 1.3% |
净利率GKOSMCS
| Q1 26 | 6.2% | — | ||
| Q4 25 | -93.4% | — | ||
| Q3 25 | -12.2% | 7.7% | ||
| Q2 25 | -15.8% | 3.6% | ||
| Q1 25 | -17.0% | -11.3% | ||
| Q4 24 | -31.8% | 0.5% | ||
| Q3 24 | -22.1% | 10.0% | ||
| Q2 24 | -52.8% | -11.5% |
每股收益（稀释后）GKOSMCS
| Q1 26 | — | — | ||
| Q4 25 | $-2.34 | — | ||
| Q3 25 | $-0.28 | — | ||
| Q2 25 | $-0.34 | — | ||
| Q1 25 | $-0.32 | — | ||
| Q4 24 | $-0.56 | — | ||
| Q3 24 | $-0.39 | — | ||
| Q2 24 | $-1.00 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $276.7M | $23.4M |
| 总债务越低越好 | — | $159.0M |
| 股东权益账面价值 | $670.9M | $457.4M |
| 总资产 | $893.3M | $1.0B |
| 负债/权益比越低杠杆越低 | — | 0.35× |
8季度趋势，按日历期对齐
现金及短期投资GKOSMCS
| Q1 26 | $276.7M | — | ||
| Q4 25 | $90.8M | $23.4M | ||
| Q3 25 | $98.2M | $7.4M | ||
| Q2 25 | $100.8M | $14.9M | ||
| Q1 25 | $114.3M | $11.9M | ||
| Q4 24 | $169.6M | $40.8M | ||
| Q3 24 | $100.1M | $28.4M | ||
| Q2 24 | $68.1M | $32.8M |
总债务GKOSMCS
| Q1 26 | — | — | ||
| Q4 25 | — | $159.0M | ||
| Q3 25 | — | $162.0M | ||
| Q2 25 | — | $179.9M | ||
| Q1 25 | — | $198.9M | ||
| Q4 24 | — | $159.1M | ||
| Q3 24 | — | $173.1M | ||
| Q2 24 | — | $175.7M |
股东权益GKOSMCS
| Q1 26 | $670.9M | — | ||
| Q4 25 | $656.2M | $457.4M | ||
| Q3 25 | $769.5M | $454.3M | ||
| Q2 25 | $765.1M | $448.4M | ||
| Q1 25 | $764.0M | $441.8M | ||
| Q4 24 | $766.9M | $464.9M | ||
| Q3 24 | $668.5M | $462.3M | ||
| Q2 24 | $665.2M | $449.4M |
总资产GKOSMCS
| Q1 26 | $893.3M | — | ||
| Q4 25 | $893.5M | $1.0B | ||
| Q3 25 | $999.4M | $1.0B | ||
| Q2 25 | $987.0M | $1.0B | ||
| Q1 25 | $966.2M | $1.0B | ||
| Q4 24 | $974.8M | $1.0B | ||
| Q3 24 | $926.5M | $1.0B | ||
| Q2 24 | $919.7M | $1.1B |
负债/权益比GKOSMCS
| Q1 26 | — | — | ||
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.45× | ||
| Q4 24 | — | 0.34× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $48.8M |
| 自由现金流经营现金流 - 资本支出 | — | $26.4M |
| 自由现金流率自由现金流/营收 | — | 13.6% |
| 资本支出强度资本支出/营收 | — | 11.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $989.0K |
8季度趋势，按日历期对齐
经营现金流GKOSMCS
| Q1 26 | — | — | ||
| Q4 25 | $6.8M | $48.8M | ||
| Q3 25 | $-10.1M | $39.1M | ||
| Q2 25 | $7.0M | $31.6M | ||
| Q1 25 | $-18.5M | $-35.3M | ||
| Q4 24 | $507.0K | $52.6M | ||
| Q3 24 | $-9.6M | $30.5M | ||
| Q2 24 | $-18.4M | $36.0M |
自由现金流GKOSMCS
| Q1 26 | — | — | ||
| Q4 25 | $3.9M | $26.4M | ||
| Q3 25 | $-11.7M | $18.2M | ||
| Q2 25 | $5.8M | $14.7M | ||
| Q1 25 | $-20.5M | $-58.3M | ||
| Q4 24 | $-1.2M | $27.1M | ||
| Q3 24 | $-11.0M | $12.0M | ||
| Q2 24 | $-20.5M | $16.1M |
自由现金流率GKOSMCS
| Q1 26 | — | — | ||
| Q4 25 | 2.7% | 13.6% | ||
| Q3 25 | -8.8% | 8.7% | ||
| Q2 25 | 4.7% | 7.1% | ||
| Q1 25 | -19.2% | -39.2% | ||
| Q4 24 | -1.2% | 14.4% | ||
| Q3 24 | -11.4% | 5.2% | ||
| Q2 24 | -21.4% | 9.2% |
资本支出强度GKOSMCS
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 11.6% | ||
| Q3 25 | 1.2% | 9.9% | ||
| Q2 25 | 0.9% | 8.2% | ||
| Q1 25 | 1.8% | 15.5% | ||
| Q4 24 | 1.6% | 13.5% | ||
| Q3 24 | 1.5% | 7.9% | ||
| Q2 24 | 2.2% | 11.3% |
现金转化率GKOSMCS
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 2.41× | ||
| Q2 25 | — | 4.32× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 53.31× | ||
| Q3 24 | — | 1.31× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GKOS
暂无分部数据
MCS
| Theatres | $123.1M | 64% |
| Concessions | $51.0M | 26% |
| Food And Beverage | $21.2M | 11% |
